Parliamentary QA
REASON FOR LONG LEAD TIME TO IMPLEMENT NEW CHANGES TO MEDISHIELD LIFE COVERAGE FOR CANCER TREATMENT
14 September 2021
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
NAME AND CONSTITUENCY OF MEMBER OF PARLIAMENT
Mr Sharael Taha,
MP for Pasir Ris-Punggol GRC
QUESTION NO. 1117
To ask the Minister for Health (a) what is the reason for the long lead time of one year to implement the new changes to MediShield Life coverage for cancer treatment; and (b) whether the changes to the MediShield Life coverage announced in August 2021 can be implemented as soon as possible rather than only in September 2022.
Written Answer
The one-year lead time allows existing patients to complete their current course of treatment and adjust their treatment plans, where needed, to alternatives which are efficacious, cost-effective and eligible for MediShield Life claims and subsidies.
The lead time is also needed for significant system changes to support claims processing and financial counselling.